Pharmaceutical R&D: Costs, Risks, and Rewards (1993)

Chapter: APPENDIX D: Congressional Access to Proprietary Pharmaceutical Industry Data

Previous Chapter: APPENDIX C: The Cost of Capital
Suggested Citation: "APPENDIX D: Congressional Access to Proprietary Pharmaceutical Industry Data." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 284
Suggested Citation: "APPENDIX D: Congressional Access to Proprietary Pharmaceutical Industry Data." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 285
Suggested Citation: "APPENDIX D: Congressional Access to Proprietary Pharmaceutical Industry Data." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 286
Suggested Citation: "APPENDIX D: Congressional Access to Proprietary Pharmaceutical Industry Data." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 287
Suggested Citation: "APPENDIX D: Congressional Access to Proprietary Pharmaceutical Industry Data." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 288
Suggested Citation: "APPENDIX D: Congressional Access to Proprietary Pharmaceutical Industry Data." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 289
Next Chapter: APPENDIX E: Patent Protection of Pharmaceuticals in the United States
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.